Postnatal Depression
Conditions
Keywords
postnatal depression, primary care, depressed women
Brief summary
A randomized clinical trial was carried out at primary care level in Santiago, Chile to investigate a combined treatment for women suffering post-natal depression and preventing the adverse consequences of this illness on infant's growth and development.
Detailed description
Background: We compared the effectiveness of a multi-component intervention with usual care to treat postnatal depression among low-income mothers in primary care clinics in Santiago, Chile. Methods: Randomised controlled trial. Two hundred and thirty mothers with major depression attending postnatal clinics were randomly allocated to either a multi-component intervention or usual care. The multi-component intervention involved a psychoeducational group, treatment adherence support, and pharmacotherapy if needed. Data were analysed on an intention-to-treat basis. The main outcome measure was the Edinburgh Postnatal Depression Scale (EPDS) at 3 and 6 months after randomisation.
Interventions
The PND-MCI included psycho-educational groups, structured pharmacotherapy if needed, and systematic monitoring of clinical progress and treatment compliance
included all services normally available in the clinics, including antidepressant medication, brief psychotherapeutic interventions or referral for specialty treatment
Sponsors
Study design
Eligibility
Inclusion criteria
* Mothers meeting criteria for current DSM-IV major depression were eligible.
Exclusion criteria
* who had received any form of treatment for their depression during their current postnatal period, * those who were pregnant, * with psychotic symptoms, * serious suicidal risk, * history of mania, * alcohol or drug abuse
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| EPDS | 3 and 6 months |
Secondary
| Measure | Time frame |
|---|---|
| four dimensions of the Short Form-36 (SF-36) Questionnaire: mental health; emotional role; social functioning; and vitality(34) and significant clinical improvement. | 3 and 6 months |